Follow the people · Insider
Robert Chess
Robert Chess files insider transactions with the SEC as a director of Twist Bioscience (TWST). We hold 3 disclosed purchases and sales filed since 19 January 2006, 1 of them in the last 90 days.
- Files forTWST
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure11 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 23 July 2019 — 7 August 2026Director · Twist Bioscience (TWST)48 Form 4 lines · source: SEC Form 4
- Filed 24 February 2006 — 30 September 2025Chairman of the Board · Nektar Therapeutics (NKTR)161 Form 4 lines · source: SEC Form 4
- Filed 3 January 2006 — 9 January 2007Director · Cotherix (CTRX)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,417 shares of Twist BioscienceSEC Form 411 August 2026Common Stock · traded 7 August 2026 · filed 11 August 2026
- ▼ sold on the open market 18,417 shares of Twist BioscienceSEC Form 411 August 2026Common Stock · traded 7 August 2026 · filed 11 August 2026
- exercised options over 18,417 shares of Twist Bioscience (a derivative holding)SEC Form 411 August 2026Stock Option (right to buy) · traded 7 August 2026 · filed 11 August 2026
- exercised options over 10,000 shares of Twist BioscienceSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 10,000 shares of Twist BioscienceSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- exercised options over 10,000 shares of Twist Bioscience (a derivative holding)SEC Form 419 March 2026Stock Option (right to buy) · traded 17 March 2026 · filed 19 March 2026
- exercised options over 10,000 shares of Twist Bioscience (a derivative holding)SEC Form 419 March 2026Stock Option (right to buy) · traded 17 March 2026 · filed 19 March 2026
- exercised options over 10,000 shares of Twist BioscienceSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 10,000 shares of Twist BioscienceSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 2,184 shares of Twist BioscienceSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- ▼ sold on the open market 2,184 shares of Twist BioscienceSEC Form 418 February 2026Common Stock · traded 13 February 2026 · filed 18 February 2026
- was granted 5,095 shares of Twist BioscienceSEC Form 49 February 2026Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 5,095 shares of Twist BioscienceSEC Form 49 February 2026Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 41 October 2025Stock Option · traded 30 September 2025 · filed 1 October 2025
- ▼ sold on the open market 2,940 shares of Twist BioscienceSEC Form 411 February 2025Common Stock · traded 7 February 2025 · filed 11 February 2025
- was granted 4,472 shares of Twist BioscienceSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- was granted 120,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 417 January 2025Stock Option · traded 18 September 2024 · filed 17 January 2025
- ▼ sold on the open market 5,000 shares of Twist BioscienceSEC Form 410 January 2025Common Stock · traded 7 January 2025 · filed 10 January 2025
- exercised options over 3,504 shares of Twist Bioscience (a derivative holding)SEC Form 430 December 2024Stock Option (right to buy) · traded 5 December 2024 · filed 30 December 2024
- exercised options over 3,504 shares of Twist BioscienceSEC Form 430 December 2024Common Stock · traded 5 December 2024 · filed 30 December 2024
- ▼ sold on the open market 2,795 shares of Twist BioscienceSEC Form 430 December 2024Common Stock · traded 5 December 2024 · filed 30 December 2024
- ▼ sold on the open market 709 shares of Twist BioscienceSEC Form 430 December 2024Common Stock · traded 5 December 2024 · filed 30 December 2024
- exercised options over 3,600 shares of Twist Bioscience (a derivative holding)SEC Form 413 November 2024Stock Option (right to buy) · traded 11 November 2024 · filed 13 November 2024
- exercised options over 3,600 shares of Twist BioscienceSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 2,324 shares of Twist BioscienceSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 1,276 shares of Twist BioscienceSEC Form 413 November 2024Common Stock · traded 11 November 2024 · filed 13 November 2024
- ▼ sold on the open market 19,500 shares of Nektar TherapeuticsSEC Form 414 June 2024Common Stock · traded 14 June 2024 · filed 14 June 2024
- was granted 5,815 shares of Twist BioscienceSEC Form 49 February 2024Common Stock · traded 6 February 2024 · filed 9 February 2024
- ▼ sold on the open market 4,110 shares of Twist BioscienceSEC Form 49 February 2024Common Stock · traded 8 February 2024 · filed 9 February 2024
- was granted 85,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 420 September 2023Stock Option · traded 19 September 2023 · filed 20 September 2023
- ▼ sold on the open market 10,200 shares of Nektar TherapeuticsSEC Form 420 September 2023Common Stock · traded 22 September 2022 · filed 20 September 2023
- was granted 8,212 shares of Twist BioscienceSEC Form 49 February 2023Common Stock · traded 7 February 2023 · filed 9 February 2023
- ▼ sold on the open market 5,100 shares of Nektar TherapeuticsSEC Form 426 September 2022Common Stock · traded 22 September 2022 · filed 26 September 2022
- was granted 20,400 shares of Nektar Therapeutics (a derivative holding)SEC Form 420 September 2022Stock Option · traded 16 September 2022 · filed 20 September 2022
- was granted 10,200 shares of Nektar TherapeuticsSEC Form 420 September 2022Common Stock · traded 16 September 2022 · filed 20 September 2022
- was granted 3,491 shares of Twist BioscienceSEC Form 410 February 2022Common Stock · traded 8 February 2022 · filed 10 February 2022
- ▼ sold on the open market 253 shares of Twist BioscienceSEC Form 48 February 2022Common Stock · traded 4 February 2022 · filed 8 February 2022
- ▼ sold on the open market 4,000 shares of Twist BioscienceSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 3,700 shares of Twist BioscienceSEC Form 425 October 2021Common Stock · traded 21 October 2021 · filed 25 October 2021
- ▼ sold on the open market 300 shares of Twist BioscienceSEC Form 421 October 2021Common Stock · traded 19 October 2021 · filed 21 October 2021
- was granted 20,400 shares of Nektar Therapeutics (a derivative holding)SEC Form 424 September 2021Stock Option · traded 22 September 2021 · filed 24 September 2021
- was granted 10,200 shares of Nektar TherapeuticsSEC Form 424 September 2021Common Stock · traded 22 September 2021 · filed 24 September 2021
- ▼ sold on the open market 4,600 shares of Nektar TherapeuticsSEC Form 424 September 2021Common Stock · traded 22 September 2021 · filed 24 September 2021
- ▼ sold on the open market 4,000 shares of Twist BioscienceSEC Form 414 September 2021Common Stock · traded 10 September 2021 · filed 14 September 2021
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- exercised options over 10,279 shares of Nektar Therapeutics (a derivative holding)SEC Form 410 September 2021Common Stock · traded 9 September 2021 · filed 10 September 2021
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- ▼ sold on the open market 8,000 shares of Nektar TherapeuticsSEC Form 410 September 2021Common Stock · traded 8 September 2021 · filed 10 September 2021
- exercised options over 10,279 shares of Nektar TherapeuticsSEC Form 410 September 2021Common Stock · traded 9 September 2021 · filed 10 September 2021
- ▼ sold on the open market 10,279 shares of Nektar TherapeuticsSEC Form 410 September 2021Common Stock · traded 9 September 2021 · filed 10 September 2021
- gave away 6,300 shares of Nektar TherapeuticsSEC Form 426 August 2021Common Stock · traded 24 August 2021 · filed 26 August 2021
- gave away 2,100 shares of Nektar TherapeuticsSEC Form 426 August 2021Common Stock · traded 24 August 2021 · filed 26 August 2021
- gave away 2,100 shares of Nektar TherapeuticsSEC Form 426 August 2021Common Stock · traded 24 August 2021 · filed 26 August 2021
- gave away 2,100 shares of Nektar TherapeuticsSEC Form 426 August 2021Common Stock · traded 24 August 2021 · filed 26 August 2021
- exercised options over 2,106 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 20 July 2021 · filed 22 July 2021
- ▼ sold on the open market 2,106 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 20 July 2021 · filed 22 July 2021
- exercised options over 3,524 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 21 July 2021 · filed 22 July 2021
- ▼ sold on the open market 3,524 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 21 July 2021 · filed 22 July 2021
- exercised options over 91 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 22 July 2021 · filed 22 July 2021
- ▼ sold on the open market 91 shares of Nektar TherapeuticsSEC Form 422 July 2021Common Stock · traded 22 July 2021 · filed 22 July 2021
- exercised options over 2,106 shares of Nektar Therapeutics (a derivative holding)SEC Form 422 July 2021Stock Option · traded 20 July 2021 · filed 22 July 2021
- exercised options over 3,524 shares of Nektar Therapeutics (a derivative holding)SEC Form 422 July 2021Stock Option · traded 21 July 2021 · filed 22 July 2021
- exercised options over 91 shares of Nektar Therapeutics (a derivative holding)SEC Form 422 July 2021Stock Option · traded 22 July 2021 · filed 22 July 2021
- ▼ sold on the open market 610 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 2,495 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 155 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 200 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 300 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 240 shares of Twist BioscienceSEC Form 414 July 2021Common Stock · traded 12 July 2021 · filed 14 July 2021
- ▼ sold on the open market 4,000 shares of Twist BioscienceSEC Form 425 June 2021Common Stock · traded 23 June 2021 · filed 25 June 2021
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 414 May 2021Stock Option · traded 12 May 2021 · filed 14 May 2021
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 414 May 2021Common Stock · traded 12 May 2021 · filed 14 May 2021
- ▼ sold on the open market 8,000 shares of Nektar TherapeuticsSEC Form 414 May 2021Common Stock · traded 12 May 2021 · filed 14 May 2021
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 416 April 2021Stock Option · traded 14 April 2021 · filed 16 April 2021
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 416 April 2021Common Stock · traded 14 April 2021 · filed 16 April 2021
- ▼ sold on the open market 8,000 shares of Nektar TherapeuticsSEC Form 416 April 2021Common Stock · traded 14 April 2021 · filed 16 April 2021
- was granted 10,588 shares of Twist Bioscience (a derivative holding)SEC Form 45 March 2021Director Stock Option (right to buy) · traded 23 July 2019 · filed 5 March 2021
- was granted 11,297 shares of Twist Bioscience (a derivative holding)SEC Form 45 March 2021Director Stock Option (right to buy) · traded 4 February 2020 · filed 5 March 2021
- ▼ sold on the open market 706 shares of Twist BioscienceSEC Form 49 February 2021Common Stock · traded 5 February 2021 · filed 9 February 2021
- was granted 486 shares of Twist BioscienceSEC Form 45 February 2021Common Stock · traded 3 February 2021 · filed 5 February 2021
- was granted 973 shares of Twist Bioscience (a derivative holding)SEC Form 45 February 2021Director Stock Option (right to buy) · traded 3 February 2021 · filed 5 February 2021
- was granted 18,200 shares of Nektar Therapeutics (a derivative holding)SEC Form 425 September 2020Stock Option · traded 22 September 2020 · filed 25 September 2020
- was granted 9,100 shares of Nektar TherapeuticsSEC Form 425 September 2020Common Stock · traded 22 September 2020 · filed 25 September 2020
- ▼ sold on the open market 5,500 shares of Nektar TherapeuticsSEC Form 425 September 2020Common Stock · traded 25 September 2020 · filed 25 September 2020
- was granted 18,200 shares of Nektar Therapeutics (a derivative holding)SEC Form 424 September 2020Stock Option · traded 22 September 2020 · filed 24 September 2020
- was granted 9,100 shares of Nektar TherapeuticsSEC Form 424 September 2020Common Stock · traded 22 September 2020 · filed 24 September 2020
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 410 September 2020Stock Option · traded 8 September 2020 · filed 10 September 2020
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 410 September 2020Common Stock · traded 8 September 2020 · filed 10 September 2020
- ▼ sold on the open market 8,000 shares of Nektar TherapeuticsSEC Form 410 September 2020Common Stock · traded 8 September 2020 · filed 10 September 2020
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 410 July 2020Stock Option · traded 8 July 2020 · filed 10 July 2020
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 410 July 2020Common Stock · traded 8 July 2020 · filed 10 July 2020
- ▼ sold on the open market 8,000 shares of Nektar TherapeuticsSEC Form 410 July 2020Common Stock · traded 8 July 2020 · filed 10 July 2020
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 417 April 2020Stock Option · traded 15 April 2020 · filed 17 April 2020
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 417 April 2020Common Stock · traded 15 April 2020 · filed 17 April 2020
- ▼ sold on the open market 7,803 shares of Nektar TherapeuticsSEC Form 417 April 2020Common Stock · traded 15 April 2020 · filed 17 April 2020
- ▼ sold on the open market 197 shares of Nektar TherapeuticsSEC Form 417 April 2020Common Stock · traded 15 April 2020 · filed 17 April 2020
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 413 March 2020Stock Option · traded 11 March 2020 · filed 13 March 2020
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 413 March 2020Common Stock · traded 11 March 2020 · filed 13 March 2020
- ▼ sold on the open market 6,800 shares of Nektar TherapeuticsSEC Form 413 March 2020Common Stock · traded 11 March 2020 · filed 13 March 2020
- ▼ sold on the open market 1,200 shares of Nektar TherapeuticsSEC Form 413 March 2020Common Stock · traded 11 March 2020 · filed 13 March 2020
- exercised options over 8,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 414 February 2020Stock Option · traded 12 February 2020 · filed 14 February 2020
- exercised options over 8,000 shares of Nektar TherapeuticsSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- ▼ sold on the open market 4,401 shares of Nektar TherapeuticsSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- ▼ sold on the open market 3,599 shares of Nektar TherapeuticsSEC Form 414 February 2020Common Stock · traded 12 February 2020 · filed 14 February 2020
- was granted 5,648 shares of Twist Bioscience (a derivative holding)SEC Form 46 February 2020Director Stock Option (right to buy) · traded 4 February 2020 · filed 6 February 2020
- was granted 1,412 shares of Twist BioscienceSEC Form 46 February 2020Common Stock · traded 4 February 2020 · filed 6 February 2020
- was granted 5,590 shares of Twist Bioscience (a derivative holding)SEC Form 49 October 2019Director Stock Option (right to buy) · traded 23 July 2019 · filed 9 October 2019
- ▼ sold on the open market 4,000 shares of Nektar TherapeuticsSEC Form 41 October 2019Common Stock · traded 27 September 2019 · filed 1 October 2019
- was granted 13,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 427 September 2019Stock Option · traded 25 September 2019 · filed 27 September 2019
- was granted 6,500 shares of Nektar TherapeuticsSEC Form 427 September 2019Common Stock · traded 25 September 2019 · filed 27 September 2019
- was granted 4,750 shares of Nektar TherapeuticsSEC Form 41 October 2018Common Stock · traded 27 September 2018 · filed 1 October 2018
- was granted 9,500 shares of Nektar Therapeutics (a derivative holding)SEC Form 41 October 2018Stock Option · traded 27 September 2018 · filed 1 October 2018
- ▼ sold on the open market 4,500 shares of Nektar TherapeuticsSEC Form 421 September 2018Common Stock · traded 19 September 2018 · filed 21 September 2018
- exercised options over 10,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 47 June 2018Stock Option · traded 5 June 2018 · filed 7 June 2018
- exercised options over 10,000 shares of Nektar TherapeuticsSEC Form 47 June 2018Common Stock · traded 5 June 2018 · filed 7 June 2018
- ▼ sold on the open market 10,000 shares of Nektar TherapeuticsSEC Form 47 June 2018Common Stock · traded 5 June 2018 · filed 7 June 2018
- exercised options over 10,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 44 May 2018Stock Option · traded 3 May 2018 · filed 4 May 2018
- exercised options over 15,000 shares of Nektar Therapeutics (a derivative holding)SEC Form 44 May 2018Stock Option · traded 3 May 2018 · filed 4 May 2018
- exercised options over 10,000 shares of Nektar TherapeuticsSEC Form 44 May 2018Common Stock · traded 3 May 2018 · filed 4 May 2018
- ▼ sold on the open market 10,000 shares of Nektar TherapeuticsSEC Form 44 May 2018Common Stock · traded 3 May 2018 · filed 4 May 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.